MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Nuvation Bio Inc. (NYSE: NUVB)*
Organization & Developments: Nuvation Bio
Parents
Nuvation Bio Inc. (NYSE: NUVB)*
Children
*Nuvation Bio Inc (NYSE: NUVB) is a clinical-stage biopharmaceutical company focused on developing differentiated and novel therapeutic candidates focused on treating patients with cancer.
2022: Hit by clinical holds for mystery eye inflammation, Nuvation drops tumor asset and reduces staff by a third
2023: Nuvation: Cash Is King, Science Is An Afterthought
2024: Nuvation Bio: Continuing To Justify A Buy Thesis With Catalysts In 2024
2024: Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate_seekingalpha.com
2025: Nuvation Bio: A Real Shot To Move The Needle In Lung Cancer Subtypes
2025: Nuvation Bio: Judgement Day Grows Closer
2025: Nuvation Bio: Pending Approval Shot In ROSL+ NSCLS Looks A Major Upside Catalyst_ seekingalpha.com
2025: Why I'm Avoiding Nuvation Bio Despite Its Recent FDA Approval
Jumps
Finance & Acquisitions: Nuvation Bio
Key People: Nuvation Bio